Macleods Pharmaceuticals Limited — Hydrochlorothiazide Exporter Profile
Indian Pharmaceutical Exporter · #11 for Hydrochlorothiazide · $29.4M export value · DGFT Verified
Macleods Pharmaceuticals Limited is the #11 Indian exporter of Hydrochlorothiazide with $29.4M in export value and 188 verified shipments. Macleods Pharmaceuticals Limited holds a 6.3% market share in Hydrochlorothiazide exports across 21 countries. The company exports 64 pharmaceutical products worth $589.8M across 20 therapeutic categories.
Macleods Pharmaceuticals Limited — Hydrochlorothiazide Export Profile: Buyers & Destinations
Where Does Macleods Pharmaceuticals Limited Export Hydrochlorothiazide?
| Country | Value | Shipments | Share |
|---|---|---|---|
| UNITED STATES | $9.1M | 392 | 69.1% |
| GREECE | $821.5K | 27 | 6.2% |
| HONDURAS | $467.4K | 28 | 3.5% |
| POLAND | $325.6K | 39 | 2.5% |
| GERMANY | $325.0K | 9 | 2.5% |
| CHILE | $298.0K | 14 | 2.3% |
| MALTA | $283.3K | 9 | 2.1% |
| SOUTH AFRICA | $228.4K | 16 | 1.7% |
| FRANCE | $162.1K | 15 | 1.2% |
| CROATIA | $147.1K | 9 | 1.1% |
Macleods Pharmaceuticals Limited exports Hydrochlorothiazide to 35 countries. The largest destination is UNITED STATES accounting for 69.1% of Macleods Pharmaceuticals Limited's Hydrochlorothiazide shipments, followed by GREECE (6.2%) and HONDURAS (3.5%). These destinations reflect Macleods Pharmaceuticals Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Hydrochlorothiazide from Macleods Pharmaceuticals Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| MACLEODS PHARMA USA INC | UNITED STATES | $3.3M | 151 |
| MACLEODS PHARMA USA,INC | UNITED STATES | $2.3M | 79 |
| MACLEODS PHARMA USA ,INC | UNITED STATES | $1.5M | 85 |
| MACLEODS PHARMA USA,INC, | UNITED STATES | $760.6K | 28 |
| DEMO SA PHARMACEUTICAL INDUSTRY | GREECE | $618.8K | 22 |
| MACLEODS PHARMA USA,INC.. | UNITED STATES | $493.1K | 12 |
| HEUMANN PHARMA GMBH & CO. | MALTA | $483.2K | 14 |
| MACLEODS PHARMA USA, INC.,. | UNITED STATES | $322.3K | 8 |
| DROGUERIA AVICENNA S,A DE C,V | HONDURAS | $258.3K | 11 |
| DEMO SA | GREECE | $202.7K | 5 |
Macleods Pharmaceuticals Limited supplies Hydrochlorothiazide to 77 buyers globally. The largest buyer is MACLEODS PHARMA USA INC (UNITED STATES), followed by MACLEODS PHARMA USA,INC (UNITED STATES) and MACLEODS PHARMA USA ,INC (UNITED STATES). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Hydrochlorothiazide Export Value and How Much Does Macleods Pharmaceuticals Limited Contribute?
India exported $119.2M worth of Hydrochlorothiazide through 6,947 shipments from 403 suppliers to 149 countries, serving 1,130 buyers globally. Macleods Pharmaceuticals Limited contributes $29.4M to this total, accounting for 6.3% of India's Hydrochlorothiazide exports. Macleods Pharmaceuticals Limited ships Hydrochlorothiazide to 35 countries through 77 buyers.
What Is the Average Shipment Value for Macleods Pharmaceuticals Limited's Hydrochlorothiazide Exports?
Macleods Pharmaceuticals Limited's average Hydrochlorothiazide shipment value is $156.3K per consignment, based on 188 shipments totaling $29.4M. The largest destination is UNITED STATES (69.1% of Macleods Pharmaceuticals Limited's Hydrochlorothiazide exports).
How Does Macleods Pharmaceuticals Limited Compare to Other Indian Hydrochlorothiazide Exporters?
Macleods Pharmaceuticals Limited ranks #11 among 403 Indian Hydrochlorothiazide exporters with a 6.3% market share. The top 3 exporters are MACLEODS PHARMACEUTICALS LTD ($25.4M), UNICHEM LABORATORIES LIMITED ($21.3M), MYLAN LABORATORIES LIMITED ($16.4M). Macleods Pharmaceuticals Limited processed 188 shipments to 21 destination countries.
What Hydrochlorothiazide Formulations Does Macleods Pharmaceuticals Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| IRBESARTAN 150MG AND HYDROCHLOROTHIAZIDE | $400.0K | 15 |
| IRBESARTAN 300MG AND HYDROCHLOROTHIAZIDE | $252.5K | 8 |
| DRUGS AND PHARMACEUTICALS HARMLESS MEDICINES VALSARTAN AND HYDROCHLOROTHIAZIDE TABLETS USP (320 MG/ 25 MG) | $204.1K | 10 |
| DRUGS AND PHARMACEUTICALS HARMLESSMEDICINES CANDESARTAN CILEXETIL AND HYDROCHLOROTHIAZIDE TABLETS USP (32 mg | $200.0K | 4 |
| DRUGS AND PHARMACEUTICALS HARMLESSMEDICINES VALSARTAN AND HYDROCHLOROTHIAZIDE TABLETS USP (160 mg/ 12.5 mg) | $178.1K | 5 |
| AMLODIPINE AND VALSARTAN HYDROCHLOROTHIAZIDE TABLETS 5/160MG(COVADIR 5 /160MG)(3X 10S TABS) | $175.7K | 9 |
| DRUGS AND PHARMACEUTICALS HARMLESS MEDICINES IRBESARTAN AND HYDROCHLOROTHIAZIDETABLETS USP 300 mg/12.5 mg | $172.0K | 8 |
| IRBESARTAN 300MG HYDROCHLOROTHIAZIDE 25M | $171.4K | 4 |
| DRUGS AND PHARMACEUTICALS HARMLESSMEDICINES VALSARTAN AND HYDROCHLOROTHIAZIDE TABLETS USP (320 mg/ 25 mg) | $150.0K | 3 |
| DRUGS AND PHARMACEUTICALS HARMLESSMEDICINES VALSARTAN AND HYDROCHLOROTHIAZIDE TABLETS USP (320 mg/ 12.5 mg) | $144.4K | 4 |
Macleods Pharmaceuticals Limited exports 457 distinct Hydrochlorothiazide formulations including tablets, capsules, syrups, and combination drugs. The top formulation is IRBESARTAN 150MG AND HYDROCHLOROTHIAZIDE with 15 shipments worth $400.0K. Notable combination products include fixed-dose combinations with other active ingredients, meeting diverse global regulatory requirements.
Regulatory Requirements: Exporting Hydrochlorothiazide to Key Markets
What Macleods Pharmaceuticals Limited must comply with to export Hydrochlorothiazide to its top destination countries
United States — FDA
Approval Process
ANDA (Abbreviated New Drug Application) for generics. Indian manufacturing site must pass FDA pre-approval inspection. Drug Master File (DMF) required for APIs.
Timeline: 10–18 months for ANDA approval
GMP & Export Requirements
FDA cGMP compliance (21 CFR 210/211); facility inspection by FDA
Drug Listing with FDA; Export Certificate from CDSCO India; Import Alert screening via FDA PREDICT system
Note: Subject to FDA Import Alerts. Open Form 483 observations can block all exports from a facility.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
How Does Macleods Pharmaceuticals Limited Compare to Nearest Hydrochlorothiazide Exporters?
Exporters ranked immediately above and below #11 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 8 | AUROBINDO PHARMA LIMITED | $4.9M | 235 | 6 | $20.7K |
| 10 | WATSON PHARMA PRIVATE LIMITED | $4.1M | 102 | 3 | $40.0K |
| 11 | MACLEODS PHARMACEUTICALS LIMITED ★ | $3.9M | 188 | 21 | $20.9K |
| 9 | CAPLIN POINT LABORATORIES LIMITED | $3.5M | 69 | 6 | $50.0K |
| 12 | SUN PHARMACEUTICAL INDUSTRIES LIMITED | $3.4M | 177 | 7 | $19.3K |
Macleods Pharmaceuticals Limited ranks #11 among 403 Indian Hydrochlorothiazide exporters. Average shipment value of $20.9K compared to the market average of $295.9K. The closest competitors by value are AUROBINDO PHARMA LIMITED and WATSON PHARMA PRIVATE LIMITED.
Which Indian Ports Ship Hydrochlorothiazide Exports?
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR | 1,041 | 15.0% |
| SAHAR AIR CARGO ACC (INBOM4) | 621 | 8.9% |
| NHAVA SHEVA SEA (INNSA1) | 621 | 8.9% |
| JNPT/ NHAVA SHEVA SEA | 493 | 7.1% |
| DELHI AIR | 319 | 4.6% |
| JNPT | 312 | 4.5% |
| Bombay Air | 252 | 3.6% |
| HYDERABAD ICD | 210 | 3.0% |
Geopolitical & Trade Policy Impact on Macleods Pharmaceuticals Limited's Hydrochlorothiazide Exports
The current geopolitical climate presents both challenges and opportunities for Indian pharmaceutical exporters like Macleods Pharmaceuticals. The Israel-Iran tensions have escalated security risks in the Red Sea and Strait of Hormuz, leading to increased shipping costs and extended transit times. Major carriers have rerouted vessels around the Cape of Good Hope, adding 10–20 days to shipments and raising freight rates by 40–50% on key India–Europe routes. (livemint.com)
Conversely, the U.S.-China trade tensions have opened avenues for Indian pharmaceutical companies to capture a larger share of the U.S. market. However, potential U.S. tariffs on Indian pharmaceutical imports pose a significant risk. A 25% tariff could render many low-margin generic drugs unprofitable, compelling companies to scale back operations or exit certain product segments, thereby exacerbating drug shortages in the U.S. (cfo.economictimes.indiatimes.com)
The recent India–European Union Free Trade Agreement, signed in January 2026, offers a favorable development by eliminating tariffs on most pharmaceutical products. This agreement is expected to enhance the competitiveness of Indian exporters in the EU market, providing a counterbalance to challenges in other regions. (en.wikipedia.org)
Macleods Pharmaceuticals Limited — Regulatory Compliance & Quality Standards
Compliance with international regulatory standards remains a cornerstone for Indian pharmaceutical exporters. Macleods Pharmaceuticals' recent recalls in the U.S. market, including the Famciclovir tablet recall due to contamination, highlight the critical need for stringent adherence to Good Manufacturing Practices (GMP). Such incidents can tarnish a company's reputation and impede market access. (pharma.economictimes.indiatimes.com)
The evolving regulatory landscape, including the EU's Falsified Medicines Directive, necessitates robust serialization and traceability measures. Indian exporters must invest in advanced compliance systems to meet these requirements, ensuring product integrity and sustaining export growth.
About Macleods Pharmaceuticals Limited
Macleods Pharmaceuticals Limited exports 64 products worth $589.8M. Beyond Hydrochlorothiazide, top products include Isoniazid, Rifampicin, Tenofovir, Valsartan, Artemether. View the complete Macleods Pharmaceuticals Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Hydrochlorothiazide — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Hydrochlorothiazide shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Macleods Pharmaceuticals Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 697 individual customs records matching Macleods Pharmaceuticals Limited exporting Hydrochlorothiazide, covering 457 formulations to 35 countries via 77 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 149+ countries, 1,130+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Hydrochlorothiazide Export Data from Macleods Pharmaceuticals Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Macleods Pharmaceuticals Limited's Hydrochlorothiazide exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Macleods Pharmaceuticals Limited
Full Company Profile →
64 products · $589.8M total trade · 20 categories
Hydrochlorothiazide Stats
Company Overview
Top Products by Macleods Pharmaceuticals Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Macleods Pharmaceuticals Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Hydrochlorothiazide. For current shipment-level data, contact TransData Nexus.